In breast cancer cell lines but not in normal cells, PHB1 is mainly localized in the nucleus and can be exported in response to a topoisomerase 1 inhibitor, camptothecin, in a CRM-1-dependent manner [16]. Here, XPO1 is linked to breast cancer.